BECKMAN COULTER Scalable Immunoassay Analyzers

NEW DxI 9000

A NEW GENERATION IMMUNOASSAY ANALYZER - First-class lab performance with Zero Daily Maintenance

Beckman Coulter DxI 9000

The New Immunoassay Analyser focused on Sensitivity & Time to First Result

EXPLORE THE DXI 9000 IMMUNOASSAY ANALYZER PEFORMANCE

EXPLORE WHAT'S UNIQUE

Click on picture

Beckman Coulter unveils the new DxI 9000 Access Immunoassay Analyzer, setting a new standard in performance and productivity for today’s busy labs with meaningful innovations that create time for you to focus on what matters most.

Zero Daily Maintenance
Eliminate daily maintenance to amplify productivity
less than 15 min. of cleaning per week

Precision Vision Technology - Learn more
More automated safeguards than other systems available on the market today

Simple Solve Onboard Guide
Has your back 24/7 with step-by-step instructions to keep things moving with less stress and more control

Beckman Coulter’s DxI 9000 Access Immunoassay Analyzer is designed to achieve faster throughput, employ an enhanced chemiluminescent substrate (Lumi-Phos PRO), deliver shorter turnaround times, run more tests per reagent pack, and provide improved user workflows,

Pathway to preparation plan.

What to expect before implementation

DxI 9000 Instrument Specifications

Data Sheet

Reimagine what’s possible with the DxI 9000

Immunoassay Analyzer to create time

Explore the DxI 9000 performance !
ZeroDaily Maintenance - PrecisionVision Technology: for real-time error detection & correction - Simple Solve Onboard Guide: helps fixes problems before they derail progress, putting control back in your hands. And more!

" With the DxI 9000, they have produced a machine that is faster, accurate, more reliable and this allows us to get the results back quicker to the patients and to the doctors for treatment"
Listen to customers talk about their experience with the NEW DxI 9000.

ACCESS 2

LOW VOLUME

Exceptional productivity in a compact design
Reliability matters. This benchtop immunoassay analyzer fits labs with space constraints and delivers fast, reliable results.
Learn more

ANNUAL TEST VOLUME <40,000
THROUGHPUT > 100 tests/hour

UniCel DxI 600

MID VOLUME

Simplicity matters. This immunoassay analyzer gives technologists the benefit of ease of use without sacrificing throughput.

Learn more

ANNUAL TEST VOLUME 40,000 to 80,000
THROUGHPUT > 200 tests/hour

UniCel DxI 800

HIGH VOLUME

Scalability matters. This immunoassay system supports the expanding needs of your growing laboratory.

Learn more

ANNUAL TEST VOLUME >80,000
THROUGHPUT > 400 tests/hour

UniCel DxI 9000

MID TO HIGH VOLUME

Your time matters. Create more of it to focus on what matters most. This immunoassay analyzer takes diagnostics to the next level.

Learn more

ANNUAL TEST VOLUME >80,000
THROUGHPUT > 450 tests/hour

Immunoassay analyzers are used to identify and detect the concentration of specific substances in patient samples, usually using an antibody as a reagent. These devices are used in hospitals and clinical laboratories to perform a variety of tests including cancer, hormonology, serology, therapeutic drug monitoring and more.
Beckman Coulter offers a variety of scalable immunoassay analyzers, which can help optimize your laboratory’s uptime, reliability and performance.

Click here to download Beckman Coulter-Immunoassay-Quick-Reference-Guide

WATCH THE VIDEO

WATCH THE VIDEO DxI FAMILY

AUTOMATED SEROLOGICAL TEST KITS ON IMMUNOASSAYS BECKMAN COULTER ANALYZERS

NEW: Beckman Coulter SARS-CoV-2 Antigen Test
Beckman Coulter’s SARS-CoV-2 Antigen Test Makes Large-scale, Serial Testing Programs Feasible
This test will help with the roll-out of mass testing in environments where people come together, such as schools, businesses, hospitals and communities. Results of the Beckman Coulter antigen test can be delivered in 30 minutes on the immunoassay analyzers Unicel DxI 800, with a testing throughput of 200 samples per hour.

SEE ALSO BECKMAN COULTER COVID-19 PROTOFOLIO

Beckman Coulter SARS-CoV2 IgM Antibody Test

In general virus infection behavior, an IgM assay will give information about current or recent infection; while IgG will, in addition, also give information about a more sustainable immune response.These two pieces of the infection story blur together when the patient takes a combined, or total IgM and IgG test. Because seroconversion is such a highly individualized journey, separate SARS-CoV-2 IgM and IgG tests can provide greater insight into where the patient is at in their infection timeline

READ MORE : Individual SARS-CoV-2 IgM Antibody Testing SARS-COV-2 IgG/IgM

ASK A QUOTATION